News
Latest News
Composed of accomplished leaders across the life science industry, together they will support innovation.
NewYorkBIO Board Member Annette Bakker's op-ed published in BioSpace discussing nonprofits role in life…
01/04/2024
NewYorkBIO convenes trade leaders from across the country to ring NYSE closing bell and kick off Biotech Month
12/22/2023
Legislation signed by Governor Hochul
12/04/2023
Join us Tuesday December 5th for another edition of our Virtual Breakfast Series featuring Don Drakeman.…
11/22/2023
NewYorkBIO's CEO, Jennifer Hawks Bland, writes in The Buffalo News.
Savings Partners
StatNews 05/03/2024
Amgen said it’s “very encouraged” by interim Phase 2 data for its obesity drug, quickly ...
05/03/2024
The drug-pricing watchdogs over at the Institute for Clinical and Economic Review tend to be ...
05/02/2024
Amgen said that it will no longer develop an early-stage obesity pill, and will instead focus on an ...
05/02/2024
This week on "The Readout LOUD" podcast: controversial brain tissue research, obesity drug sales, ...
05/02/2024
Novo Nordisk on Thursday defended the prices of its blockbuster diabetes and obesity drugs Ozempic ...
05/02/2024
Today's biotech news updates include Novo Nordisk strong sales, bird flu in milk, and Novartis' ...
05/02/2024
Check out the latest edition of Adam's Biotech Scorecard, a new newsletter from @statnews.
05/02/2024
BridgeBio Pharma is spinning out its oncology subsidiary into a fully independent company, as it ...
05/02/2024
Novartis already produces the leading drug in the radiopharmaceutical field. Now, it is devoting ...